Bioenvision
Engages in the acquisition, development and marketing of compounds and technologies primarily for the treatment of cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD533m (Public information from May 2007)
New York City New York (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$7.4m | Early VC | ||
$345m Valuation: $345m | Acquisition | ||
| Total Funding | AUD11.4m | ||
Related Content
Recent News about Bioenvision
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.